Anthony J. Hunt
AdvisorMr. Anthony J. Hunt, also known as Tony, is Director since April 2026 and was Strategic Advisor of Oribiotech Ltd until April 2026. Mr. Hunt serves as Independent Director of BioLife Solutions, Inc. since January 2, 2025. He was Executive Chair of Repligen Corporation from September 1, 2024 until March 13, 2026. Mr. Hunt was Director of Repligen Corporation since May 2015 until March 13, 2026 and had been its Member of Scientific Advisory Board since March 2016. Mr. Hunt will remain Repligen Corporation as advisor through March 2027. Mr. Hunt was CEO & Director of Repligen Corporation from October 02, 2023 to September 1, 2024. He joined Life Technologies in 2008, serving as General Manager of Bioproduction Chromatography and Pharma Analytics before being named President of Bioproduction in 2011. Mr. Hunt serves as Independent Director at 908 Devices Inc. since March 2, 2022. He has been the Chief Executive Officer of Repligen Corporation since May 21, 2015 and served as its President since May 21, 2015 until October 02, 2023. Mr. Hunt served as Secretary of Repligen Corporation. He served as Chief Operating Officer of Repligen Corporation since May 6, 2014 until May 21, 2015 and joined in May 2014. Mr. Hunt served as President of BioProduction at Life Technologies since 2011. He played a key role in the development and growth of Life Technologies's bioprocessing business, where he focused on expanding the upstream Gibco(R) cell culture franchise and building the downstream purification and analytics franchises. Mr. Hunt oversee commercial and manufacturing operations for Repligen. He joined Life Technologies in 2008, first as General Manager of BioProduction Chromatography and Pharma Analytics before being named President, BioProduction in 2011. In this most recent role, where he led an organization of approximately 200 employees, his responsibilities included commercial operations and research and development, as well as product management and marketing. Prior to this role, Mr. Hunt was with Applied Biosystems for many years, served as Senior Director of Pharma Programs since 2000 until 2008, where he launched the pharma analytics business that in 2008 became a part of the bioproduction platform at Life Technologies. Mr. Hunt began his career with Repligen where he was involved in process development. Mr. Hunt received a Bachelors of Science degree in microbiology from University College Galway, Ireland, a Masters of Science degree in biotechnology from University College Galway, Ireland and a Masters of Business Administration from Boston University School of Management.
Positions
- Company NameRepligen CorporationStock CodeRGENPositionAdvisorColleagues
- OLOlivier LoeillotPresident, CEO & Director
- MDMartin D. MadausIndependent Chair of the Board
- JKJason K. GarlandCFO & Chief Compliance Officer
- JRJames R. BylundChief Operating Officer
- RKRalf KuriyelSenior Vice President of Research & Development
- GPGlenn P. MuirIndependent Director
- MAMargaret A. PaxIndependent Director
- NMNicholas M. BarthelemyIndependent Director
